US approves new Covid-19 antibody drug for high-risk patients

8 December 2021, 22:14

Virus Outbreak Antibody Drug
Virus Outbreak Antibody Drug. Picture: PA

The FDA and other health authorities have stressed that antibody drugs are not a substitute for vaccines.

US federal health officials have authorised a new Covid-19 antibody drug for people with serious health problems or allergies who cannot get adequate protection from vaccination.

Antibody drugs have been a standard treatment for treating Covid infections for more than a year. But the AstraZeneca antibody drug cleared by the Food and Drug Administration is different.

It is the first authorised for long-term prevention against Covid-19 infection, rather than a short-term treatment.

Covid-19 vaccine
Some people do not respond to vaccines (Kirsty O’Connor/PA)

People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs for conditions like rheumatoid arthritis.

Health experts estimate about 2% to 3% of the US population falls into that group.

“These people still have to shelter in place because they’re at really high risk of severe disease and death,” said Dr David Boulware of the University of Minnesota, ahead of the announcement.

“So having this therapy will enable a lot of them to get back to their normal lives.”

Specifically, the FDA authorised the AstraZeneca drug called Evusheld for adults and children 12 and older whose immune systems have not responded adequately to Covid-19 vaccines or have a history of severe allergic reactions to the shots.

Regulators said the required two antibody injections may be effective at preventing Covid-19 infections for six months.

Like similar drugs, AstraZeneca’s delivers laboratory-made versions of human antibody proteins, which help the immune system fight off viruses and other infections.

The FDA and other health authorities have stressed that antibody drugs are not a substitute for vaccines, which are the most effective, long-lasting and economical form of virus protection.

Antibody drugs are tricky to manufacture and often cost a lot more per dose compared with vaccines.

The FDA has authorised three other antibody therapies from Regeneron, Eli Lilly and GlaxoSmithKline, with the US government purchasing hundreds of thousands of doses.

All require an IV or injection. They are used to treat people with recent infections who have the highest risk of progressing to severe Covid-19 because of other health issues. Two can be used to prevent infection after a possible coronavirus exposure.

AstraZeneca’s drug would be used differently — only as a long-term preventive measure in people who have increased vulnerability to the virus.

In a company study, people who received Evusheld had a 77% lower risk of infection than people who received a dummy shot over six months, the FDA said.

By Press Association

Latest World News

See more Latest World News

Former US president Donald Trump arrives at Trump Tower, late on Tuesday August 9 2022, in New York

Donald Trump arrives to give evidence in New York investigation

Taiwan’s military conducts artillery live-fire drills at Fangshan township in Pingtung, southern Taiwan, Tuesday, August 9, 2022

China appears to wind down threatening war games near Taiwan

People line up to enter an H&M shop and buy items on sale in the Aviapark shopping centre in Moscow, Russia, on Tuesday August 9 2022

Russians buy last goods from H&M and Ikea as stores wind down

Tom Daley blames 'legacy of colonialism' for homophobia in the Commonwealth

Tom Daley blames British Empire's legacy of colonialism' for homophobic laws in Commonwealth nations

France Whale in Seine

Beluga whale stranded in French river dies, authorities say

Rising smoke can be seen from the beach at Saky after explosions were heard from the direction of a Russian military airbase near Novofedorivka, Crimea

Ukraine says nine Russian warplanes were destroyed in Crimea blasts

French police shoot dead knifeman in Charles de Gaulle airport

Knifeman shot dead by police in packed terminal at Paris's biggest airport

Russia Ukraine

Large explosions rock Russian air base in Crimea

Chinese officials shared images from social media site Weibo of the Chinese military drills.

China's new invasion threat as it warns it is 'ready to use all necessary measures' to retake Taiwan

This photo released Tuesday, August 9, 2022, by the Albuquerque Police Department shows Muhammad Syed, 51, who was taken into custody on Monday in connection with the killings of four Muslim men in Albuquerque, New Mexico, over the last nine months

‘Motive unclear’ as man charged with killing fellow Muslims in Albuquerque

Yaser Said walks into the courtroom for his trial, Tuesday, August 9, 2022, in the Frank Crowley Criminal Courts Building in Dallas

‘Abusive’ father who evaded police for 12 years convicted of killing daughters

Albuquerque Muslim Killings

Man charged with killing two Muslim men in US city

Emmett Till

Grand jury declines to indict woman whose accusation set off lynching in 1955

Albuquerque Muslim Killings

‘Primary suspect’ held over killings of Muslim men in New Mexico

Israel Palestinians

Militants killed by Israeli troops in West Bank as violence resumes

Kenya Elections

Kenya’s close presidential election draws fewer voters